A Multi-center, Prospective, Randomized, Double-blind Study to Assess the Impact of Sacubitril/Valsartan vs. Enalapril on Daily Physical Activity Using a Wrist Worn Actigraphy Device in Adult Chronic Heart Failure Patients
Phase of Trial: Phase III
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Enalapril
- Indications Chronic heart failure
- Focus Registrational; Therapeutic Use
- Acronyms OUTSTEP-HF
- Sponsors Novartis
- 03 Oct 2017 Planned End Date changed from 22 Jan 2018 to 5 Jul 2018.
- 03 Oct 2017 Planned primary completion date changed from 22 Jan 2018 to 5 Jul 2018.
- 18 Aug 2017 Planned End Date changed from 1 Jan 2018 to 22 Jan 2018.